Sanofi's diabetes drug Lyxumia approved in Europe

PARIS (Reuters) - Sanofi said on Monday regulators have approved Lyxumia, a diabetes treatment, for sale in the 27 member states of Europe. The drug, also known by its generic name lixisenatide, is an injectable to be taken once a day in conjuction with other drugs or insulin by patients who are otherwise not able to control their blood sugar levels. (Reporting by Leila Abboud; editing by Blaise Robinson) via Health News Headlines - Yahoo! News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/02/sanofi-diabetes-drug-lyxumia-approved_4.html